Qualigen Therapeutics, Inc.

NASDAQ (USD): Qualigen Therapeutics, Inc. (QLGN)

Last Price

3.63

Today's Change

-0.211 (5.48%)

Day's Change

3.40 - 3.95

Trading Volume

113,087

Overview

Market Cap

2 Million

Shares Outstanding

736,431

Avg Volume

87,934

Avg Price (50 Days)

3.29

Avg Price (200 Days)

6.27

PE Ratio

0.00

EPS

3635.00

Earnings Announcement

24-Apr-2025

Previous Close

3.85

Open

3.62

Day's Range

3.4 - 3.9499

Year Range

2.85 - 29.45

Trading Volume

113,087

Price Change Highlight

1 Day Change

-5.47%

5 Day Change

13.37%

1 Month Change

11.98%

3 Month Change

-14.37%

6 Month Change

-32.73%

Ytd Change

-13.35%

1 Year Change

-76.44%

3 Year Change

-98.82%

5 Year Change

-99.92%

10 Year Change

-100.00%

Max Change

-100.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment